Chronic kidney disease (CKD), affecting 35.5 million Americans, remains underdiagnosed and poorly managed, with only half of those affected receiving a formal diagnosis. Assistant Professor Eleanor Rivera highlights the critical need for increased awareness and timely intervention, especially for patients in early stages who often lack essential information from healthcare providers. This oversight can lead to advanced CKD, necessitating burdensome treatments like dialysis, which significantly impact quality of life.

The implications for the longevity and healthspan fields are profound. With high blood pressure and diabetes as primary risk factors, early detection and management of CKD could prevent progression to kidney failure. Innovations such as SGLT2 inhibitors show promise in protecting kidney function, yet many patients remain uninformed about their risks and treatment options, particularly those from marginalized backgrounds.

A key takeaway is the importance of proactive patient engagement in discussions about kidney health. Encouraging patients to inquire about their kidney function can lead to better outcomes and adherence to treatment plans. For a deeper dive into these findings and strategies, I recommend exploring the full article.

Source: superagingnews.com